Hospital De Galdakao Usansolo — Clinical Trial Site

39 Registered trials

18 Currently recruiting

Organisation

Hospital De Galdakao Usansolo

Location

Galdakao, Spain

Identifier

ORG-100045182

Address

Leku Barrio Labeaga 46 A, 48960, Spain

Departments

-
Angiology and Vascular Sugery
Cardiología
CARDIOLOGY
Cirugía general
CIRUGIA VASCULAR Y ANGIOLOGIA
Digestive
Digestive system
Digestivo
Gastroenterología
Gastroenterology
Hematología
Hematology
Medical Oncology
Neumología
Neumology
Oncología
Oncology
Oncology department
Oncology Service
Pneumology
Seccion de Hemodinamica
Servicio de Aparato Digestivo, Unidad de Enfermedad Inflamatoria Intestinal
Servicio de Gastroenterología
Servicio de Neumología
Servicio de Reumatología
UROLOGIA

Clinical trials at this site (39)

Search interface

PEITHO-3 - A reduced dose of thrombolytic treatment for patients with intermediate high-risk acute pulmonary embolism: a randomized controll… Ended

2024-511321-54-00 intermediate-high-risk acute pulmonary embolism 5 2021-08-04
Sacituzumab Govitecan in primary HER2-negative breast cancer (SASCIA) Ended

2023-510390-33-00 HER2-negative breast cancer patients with high relapse 5 2020-10-23
IMPACT OF INTRAVENOUS IRON TREATMENT OF PREOPERATIVE ANEMIA IN PATIENTS WITH LOWER EXTREMITY PERIPHERAL ARTERY DISEASE (IRONPAD) Ended

2024-514593-50-00 Anemia in patients with chronic ischemia of the lower l 6 2019-06-06
A study to test whether BI 1819479 improves lung function in people with idiopathic pulmonary fibrosis (IPF). Ended

2023-508395-11-00 idiopathic pulmonary fibrosis 4 2024-09-10
A study to test whether BI 1839100 improves cough in people with idiopathic pulmonary fibrosis or progressive pulmonary fibrosis Ended

2023-510249-79-00 Progressive pulmonary fibrosis (PPF) 4 2024-09-10
THE ANTES B+ STUDY: AN OPEN-LABEL, PRAGMATIC, RANDOMIZED, CONTROLLED TRIAL OF TRIPLE THERAPY VERSUS LABA-LAMA COMBINATION TO IMPROVE CLINICA… Ended

2023-507304-32-00 Chronic Obstructive Pulmonary Disease 6 2024-02-09
Phase II trial of trastuzumab deruxtecan in first-line treatment HER2-positive locally advanced or metastatic breast cancer (MBC) patients c… Ended

2023-503627-26-00 Metastatic breast cancer 4 2023-09-28
Phase 2/3 Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer Ended

2022-502196-31-00 Advanced or Recurrent Endometrial Cancer 10 2023-08-21
Long-term Efficacy and Safety of Tozorakimab in Participants with Chronic Obstructive Pulmonary Disease with a History of Exacerbations. Ended

2022-501063-41-00 Chronic Obstructive Pulmonary Disease (COPD) 5 2023-04-20
A study to find out whether BI 1015550 improves lung function in people with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs) Ended

2024-512803-37-00 Progressive Fibrosing Interstitial Lung Diseases (PF-IL 5 2022-10-05
Study to assess efficacy, safety, and tolerability of Tozorakimab in patients with symptomatic chronic obstructive pulmonary disease (COPD) … Ended

2023-503571-19-00 Chronic Obstructive Pulmonary Disease (COPD) 5 2022-01-20
A phase III trial of trastuzumab + ALpelisib +/- fulvestrant versus trastuzumab + chemotherapy in patients with PIK3CA mutated previously tr… Ended

2024-514611-98-00 PIK3CA mutated HER2+ advanced or relapsed breast cancer 5 2021-07-20
A Randomized, Double-Blind, Phase III Clinical Trial of Neoadjuvant Chemotherapy with Atezolizumab or Placebo in Patients with Triple-Negati… Ended

2023-508472-11-00 Patients with early breast cancer 5 2018-06-13
autologous Transplantation after a Rituximab/Ibrutinib/Ara-c containing iNduction in Generalized mantle cell Lymphoma – a randomized Europea… Ended

2024-511235-10-00 Generalized mantle cell Lymphoma 5 2016-07-25
IMPACT OF LEVOTHYROXINE ON ERECTILE FUNCTION IN PATIENTS WITH HYPOTHYROIDISM Ended

2024-514789-38-00 erectile function 6